Literature DB >> 35460647

Assortative mixing among vaccination groups and biased estimation of reproduction numbers.

Colin Klaus1, Matthew Wascher2, Wasiur R KhudaBukhsh3, Joseph H Tien4, Grzegorz A Rempała5, Eben Kenah6.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35460647      PMCID: PMC9020805          DOI: 10.1016/S1473-3099(22)00155-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   71.421


× No keyword cloud information.
Assortative mixing, wherein there is more mixing within infection risk groups than would be expected to occur at random, has long been known to affect epidemic dynamics. A classic example comes from sexually transmitted diseases, for which assortative mixing within groups that have different levels of sexual activity increases the initial growth rate of the infection and the basic reproduction number (R 0) compared to the same population with more random choices of sexual partners. Assortative mixing within age groups has also been shown to affect dynamics and statistical inference for diseases spread through respiratory droplets, which motivates the widespread use of age-structured contact matrices in epidemic models. More recent studies3, 4 have shown that assortative mixing with respect to vaccination status can affect outbreak sizes and estimates of vaccine efficacy in network-based epidemic models. We hypothesised that assortative mixing among vaccination groups (vaccinated and unvaccinated) might be a source of bias in population-level estimates of the effective reproduction number (R) for the delta (B.1.617.2) variant of SARS-CoV-2. With a fixed total rate of contact between individuals, a lower R is required to explain a given incidence of new infections when unvaccinated individuals preferentially contact other unvaccinated individuals. The prevalence of vaccination varies greatly across rural and urban areas as well as other social groupings within which assortative mixing is likely. According to Ohio Department of Health (ODH) data, the prevalence of vaccination among adults in Ohio, USA, counties ranges from slightly under 20% to slightly under 70%, with an overall prevalence of approximately 55%. To explore the potential impact of assortative mixing on estimation of R we modified an age-stratified Susceptible-Exposed-Infected-Removed model of SARS-CoV-2 transmission in the state of Ohio to allow for assortative mixing within vaccination groups. This model was parameterised and fit using data from the ODH, the Centers for Disease Control and Prevention (CDC), and the United States Census Bureau. The contact matrix for age groups and some other parameters were taken from Prem and colleagues and Bubar and colleagues. The model R is the spectral radius of the next-generation matrix. To make the rate of between-group contact ρ (≤1) times the rate of within-group contact, we multiply each within-group contact rate βii by a and each between-group contact rate βij by ρa. The factor a ensures that the total rate of contact is not changed, and it is found by solving the following equation, in which n 0 is the number of unvaccinated individuals and n 1 is the number of vaccinated individuals. For a sufficiently large n that nC2 ≈ n  ÷ 2, we get As intended, this gives us a=1 when ρ=1. For several choices of ρ, we fit ODH daily reported incident cases using a Bayesian inference approach in which posterior distributions were sampled using a hybrid Markov chain Monte Carlo scheme (appendix). Figure 1 shows a histogram of the posterior distribution of R and the fit to daily ODH incidence data. Although the estimates of R differ considerably, there is almost no difference in the fit of the model to daily incident cases reported to ODH.
Figure

Role for anti-SARS-CoV-2 antibodies in the disease course of COVID-19

As disease states progress from preinfection through to critical illness (blue boxes), the potential for antibodies to mitigate illness decreases (dark blue arrow) as pathology transitions from being virally mediated, where antiviral acting therapies are most effective (green triangle), to a hyper-inflammatory state best treated with immunomodulatory therapies (orange triangle).

Role for anti-SARS-CoV-2 antibodies in the disease course of COVID-19 As disease states progress from preinfection through to critical illness (blue boxes), the potential for antibodies to mitigate illness decreases (dark blue arrow) as pathology transitions from being virally mediated, where antiviral acting therapies are most effective (green triangle), to a hyper-inflammatory state best treated with immunomodulatory therapies (orange triangle). Despite the potential importance of assortative mixing among vaccination groups in understanding SARS-CoV-2 transmission, there is almost no quantitative empirical research available on this topic. A search using the Google search engine for phrases such as “covid19 + assortative mixing + vaccination” on Oct 25, 2021, returned about 87 000 results, of which the most relevant referred to age-assortative mixing and its potential impact on vaccination strategies. A search for the same terms using Google Scholar on the same day returned more than 400 hits, with the most relevant emphasising the interplay between age-assortative mixing and vaccination. Although the epidemic modelling community routinely incorporates age-structured mixing matrices, assortative mixing among groups defined by other risk factors for infection are potential sources of bias in estimating epidemic parameters and the impact of interventions. Vaccination is one of the most important determinants of the risk of infection with SARS-CoV-2 in regions where a vaccine is widely available. An overestimation of R could lead to undue pessimism about our ability to control the COVID-19 pandemic through vaccination and physical distancing. The POLYMOD study shows how social survey methods could be used to better understand mixing patterns in an epidemic. Our simple experiment shows that such surveys could address an important gap in our ability to analyse the population-level transmission of disease and, by extension, to design and evaluate public health interventions in future epidemics. We declare no competing interests.
  7 in total

1.  Networks of sexual contacts: implications for the pattern of spread of HIV.

Authors:  S Gupta; R M Anderson; R M May
Journal:  AIDS       Date:  1989-12       Impact factor: 4.177

2.  Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents.

Authors:  Jacco Wallinga; Peter Teunis; Mirjam Kretzschmar
Journal:  Am J Epidemiol       Date:  2006-09-12       Impact factor: 4.897

3.  Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era.

Authors:  Kiesha Prem; Kevin van Zandvoort; Petra Klepac; Rosalind M Eggo; Nicholas G Davies; Alex R Cook; Mark Jit
Journal:  PLoS Comput Biol       Date:  2021-07-26       Impact factor: 4.475

4.  Assortativity and Bias in Epidemiologic Studies of Contagious Outcomes: A Simulated Example in the Context of Vaccination.

Authors:  Paul N Zivich; Alexander Volfovsky; James Moody; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2021-11-02       Impact factor: 5.363

5.  Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity.

Authors:  Victoria C Barclay; Timo Smieszek; Jianping He; Guohong Cao; Jeanette J Rainey; Hongjiang Gao; Amra Uzicanin; Marcel Salathé
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.

Authors:  Kate M Bubar; Kyle Reinholt; Stephen M Kissler; Marc Lipsitch; Sarah Cobey; Yonatan H Grad; Daniel B Larremore
Journal:  Science       Date:  2021-01-21       Impact factor: 47.728

7.  Social contacts and mixing patterns relevant to the spread of infectious diseases.

Authors:  Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Journal:  PLoS Med       Date:  2008-03-25       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.